GASTROENTEROLOGY
Comprehensive Care for Digestive Health
Heveren’s Gastroenterology range offers clinically-proven solutions to manage and treat common and chronic gastrointestinal conditions. Our products are designed to support gut health, relieve acid reflux, manage irritable bowel symptoms, and aid in nutrient absorption, contributing to overall digestive wellness.
Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves.
About 830 million people worldwide have diabetes, the majority living in low-and middle-income countries. In India, there are estimated 77 million people above the age of 18 years are suffering from diabetes and nearly 25 million are prediabetics.
The most common is type 2 diabetes, usually in adults, which occurs when the body becomes resistant to insulin or doesn’t make enough insulin.
Type 1 diabetes, once known as juvenile diabetes or insulin dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin.
More than 50% of people are unaware of their diabetic status which leads to health complications if not detected and treated early
Voglibose 0.2 and 0.3 mg Tablets
Voglibose 0.2/0.3mg and Metformin 500mg PR Tablets
Glimepiride 1/2mg and Metformin 500mg SR Tablets
Glimepiride 1/2mg and Voglibose 0.2 mg and Metformin 500mg SR Tablets
Vildagliptin 50mg Tablets
Vildagliptin 50mg and Metformin 500mg/1000mg Tablets
Gastroesophageal reflux disease (GERD) is a chronic gastrointestinal disorder that leads to the regurgitation of gastric contents into the esophagus.
Dyspepsia, the medical term for indigestion, refers to discomfort or pain in the upper abdomen, often after eating or drinking. It is not a disease but a symptom of GERD.
Dyspepsia is a common problem, affecting up to 20% of the population.
Peptic ulcer disease (PUD) is characterized by discontinuation in the inner lining of the gastrointestinal tract because of gastric acid secretion.
Around More than 1 million cases per year reported in India of peptic disorder. PUD is a global problem with a lifetime risk of development ranging from 5% to 10%.